Here's the live share price of SMS Lifesciences India along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of SMS Lifesciences India has gained 12.80% CAGR. Over the past year, the corresponding return has been -19.63%.
SMS Lifesciences India’s current P/E of 20.93x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
SMS Lifesciences India | -0.05 | 8.98 | 7.71 | 6.84 | -19.63 | 19.88 | 12.80 |
Sun Pharmaceutical Industries | 2.46 | 1.83 | 0.53 | -4.47 | -10.31 | 23.72 | 26.88 |
Divi's Laboratories | 2.72 | 1.77 | -4.66 | 6.42 | 13.89 | 19.59 | 14.40 |
Cipla | 0.10 | 1.71 | 6.22 | 5.14 | -3.85 | 15.04 | 15.46 |
Torrent Pharmaceuticals | 2.14 | -0.21 | 14.98 | 14.09 | 8.71 | 35.04 | 21.92 |
Dr. Reddy's Laboratories | 0.55 | 6.29 | -0.21 | 12.94 | 1.71 | 17.31 | 5.19 |
Mankind Pharma | 3.11 | 6.77 | 14.52 | 23.06 | 9.42 | 23.16 | 13.31 |
Zydus Lifesciences | -0.75 | 4.85 | 9.18 | 14.01 | -1.65 | 42.32 | 21.23 |
Lupin | 0.75 | 4.56 | 6.49 | -0.13 | -5.17 | 47.48 | 14.61 |
Alkem Laboratories | 2.04 | 3.13 | 16.34 | 14.54 | -9.45 | 19.64 | 14.17 |
Aurobindo Pharma | 2.17 | 2.57 | 3.24 | -3.89 | -26.78 | 29.10 | 7.17 |
Abbott India | -1.82 | -8.05 | -1.97 | 0.22 | 8.72 | 20.47 | 13.85 |
Glenmark Pharmaceuticals | -2.16 | 7.13 | 27.12 | 40.23 | 26.25 | 77.84 | 34.53 |
Laurus Labs | 4.19 | 5.51 | 44.52 | 54.04 | 98.51 | 22.52 | 26.75 |
Biocon | 1.26 | 1.57 | 6.05 | 8.19 | 2.48 | 8.42 | -2.92 |
Anthem Biosciences | 1.98 | 3.87 | 16.36 | 16.36 | 16.36 | 5.18 | 3.08 |
GlaxoSmithKline Pharmaceuticals | -1.38 | -2.86 | -14.32 | -3.47 | 1.40 | 24.71 | 10.06 |
Ipca Laboratories | 6.86 | 1.39 | 3.24 | 3.63 | -3.35 | 17.89 | 6.17 |
Cohance Lifesciences | -7.40 | -1.19 | -8.09 | -21.72 | -22.85 | 25.51 | 19.13 |
Gland Pharma | 0.04 | 3.93 | 18.34 | 27.73 | 11.67 | -3.43 | 2.12 |
Over the last one year, SMS Lifesciences India has declined 19.63% compared to peers like Sun Pharmaceutical Industries (-10.31%), Divi's Laboratories (13.89%), Cipla (-3.85%). From a 5 year perspective, SMS Lifesciences India has underperformed peers relative to Sun Pharmaceutical Industries (26.88%) and Divi's Laboratories (14.40%).
Day | SMA | EMA |
---|---|---|
5 | 1,204.29 | 1,206.26 |
10 | 1,173.57 | 1,188.03 |
20 | 1,149.24 | 1,167.73 |
50 | 1,156.51 | 1,166.42 |
100 | 1,213.23 | 1,186.17 |
200 | 1,207.92 | 1,178.18 |
In the latest quarter, SMS Lifesciences India remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding rose to 0.03%, and public shareholding moved down to 28.56% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 16, 2025, 12:11 AM IST | SMS Lifesciences Ind - Report (Special Window) |
Sep 09, 2025, 8:45 PM IST | SMS Lifesciences Ind - Annual Report (Weblink) |
Sep 07, 2025, 12:43 AM IST | SMS Lifesciences Ind - Newspaper Advertisement (AGM Notice) |
Sep 07, 2025, 12:39 AM IST | SMS Lifesciences Ind - Reg. 34 (1) Annual Report. |
Sep 07, 2025, 12:07 AM IST | SMS Lifesciences Ind - AGM Notice (Sept 30, 2025) |
SMS Lifesciences India Ltd. is a Public Limited Listed company incorporated on 31/05/2006 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L74930TG2006PLC050223 and registration number is 050223. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 333.37 Cr. and Equity Capital is Rs. 3.02 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for SMS Lifesciences India is ₹1,195.50 as on Sep 19, 2025.
The SMS Lifesciences India is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of SMS Lifesciences India is ₹361.43 Cr as on Sep 19, 2025.
Today’s highest and lowest price of SMS Lifesciences India are ₹1,224.15 and ₹1,195.50.
The 52-week high/low is the highest and lowest price at which SMS Lifesciences India stock has traded in the past 52-week or nearly a year. The 52-week high of SMS Lifesciences India is ₹1,688.00 and 52-week low of SMS Lifesciences India is ₹956.05 as on Sep 19, 2025.
The SMS Lifesciences India has shown returns of -2.32% over the past day, 8.98% for the past month, 7.71% over 3 months, -19.63% over 1 year, 19.88% across 3 years, and 12.8% over 5 years.
P/E ratio of and PB ratio of SMS Lifesciences India are 20.93 and 1.92 on Sep 19, 2025. While the company gives a dividend yield of 0.13 per annum.